Skip to main content
SpringerLink
Log in

Effect of Gemfibrozil Administration on Biliary Lipid Secretion: A Crossover Study with Clofibrate

  • Conference paper
Drugs Affecting Lipid Metabolism

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

  • 210 Accesses

Abstract

It is generally recognised that several drugs successfully used to reduce serum cholesterol and triglycerides also interfere with biliary lipid metabolism (Von Bergmann and Leiss 1984).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bateson MC, Maclean D, Ross PE (1978) Clofibrate therapy and gallstone induction. Dig Dis 23: 623–628

    Article  CAS  Google Scholar 

  • Cooper T, Geizerova M, Oliver MF (1975) Clofibrate and gallstones. Lancet 1:1083

    Article  PubMed  CAS  Google Scholar 

  • Grundy SM, Metzger AL (1972) A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200–1217

    PubMed  CAS  Google Scholar 

  • Hall MJ, Nelson LM, Russel RI (1981) Gemfibrozil, the effect on biliary cholesterol saturation of a new lipid-lowering agent and its comparison with Clofibrate. Atherosclerosis 39:511–516

    Article  PubMed  CAS  Google Scholar 

  • Kankola S, Manninen V, Haikonen M (1981) Gemfibrozil in the treatment of dyslipidemias in middle-aged male survivors of myocardial infarction. Acta Med Scand 209:69–73

    Article  Google Scholar 

  • Kesäniemi YA, Grundy SM (1984) Influence of Gemfibrozil on metabolism of cholesterol and plasma triglycerides in man. JAMA 251:2241–2246

    Article  PubMed  Google Scholar 

  • Leiss O, von Bergmann K, et al. (1985) Effect of Gemfibrozil on biliary lipid metabolism in nor-molipidemic subjects. Metabolism 34:74–82

    Article  PubMed  CAS  Google Scholar 

  • O’Connor RE (1982) Gemfibrozil: results of clinical studies in the United States. In: Ricci G, Paoletti R, Pocchiari F (eds) Therapeutic selectivity and risk benefit assessment of hypolipidemic drugs. Raven, New York, pp 59–61

    Google Scholar 

  • Von Bergmann K, Leiss O (1984) Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipidemia. Eur J Clin Invest 14:150–154

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Clinica Medica III e Gastroenterologia, Universita di Bologna, Policlinico S. Orsola, Via Massarenti, 9, Bologna, Italy

    F. Bazzoli

Authors
  1. L. Barbara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Mazzella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Villanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Simoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Ronchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Roda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Roda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Bazzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of Milan, Via Balzaretti 9, 20133, Milan, Italy

    Rodolfo Paoletti (Dean) (Dean)

  2. The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA

    David Kritchevsky (Associate Director) (Associate Director)

  3. 238 Chatham Way, West Chester, PA, 19380, USA

    William L. Holmes

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Barbara, L. et al. (1987). Effect of Gemfibrozil Administration on Biliary Lipid Secretion: A Crossover Study with Clofibrate. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_65

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71702-4_65

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71704-8

  • Online ISBN: 978-3-642-71702-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation